All these indicate that the biological role of SAMD13 enriched in “regulation of nucleic acid metabolic process” and “cell cycle regulation” participates in acquired chemotherapy resistance and translational process, further supporting a role for CpG methylation of SAMD13 linked with worse prognosis in patients with HCC. This evidence concerns the gene SAMD13 and hepatocellular carcinoma.